WPI 2227 (Flutamide 125 mg)
Pill with imprint WPI 2227 is Brown & White, Capsule-shape and has been identified as Flutamide 125 mg. It is supplied by Watson Pharmaceuticals, Inc.
Flutamide is used in the treatment of hirsutism; prostate cancer and belongs to the drug classes antiandrogens, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Flutamide 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 2227
Flutamide
- Imprint
- WPI 2227
- Strength
- 125 mg
- Color
- Brown & White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiandrogens, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 00591-2466 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
povidone,
corn starch,
sodium lauryl sulfate,
ferrosoferric oxide,
gelatin,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
butyl alcohol,
propylene glycol
Note: Inactive ingredients may vary.
More about flutamide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Drug images
- Pricing & coupons
- En español
- Drug class: antiandrogens
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.